Revised SPCs: Imnovid (pomalidomide) hard capsules

New information on use in the paediatric population has been added to sections 4.8 (undesirable effects), 5.1 (pharmacodynamic properties) and 5.2 (pharmacokinetic properties).

electronic Medicines compendium